Candida infective endocarditis: Report of 15 cases from a prospective multicenter study

Medicine

Volumn 88, Issue 3, 2009, Pages 160-168

  Falcone, Marco ^a   Barzaghi, Nicoletta ^a   Carosi, Giampiero ^b   Grossi, Paolo ^c   Minoli, Lorenzo ^d   Ravasio, Veronica ^e   Rizzi, Marco ^e   Suter, Fredy ^e   Utili, Riccardo ^f   Viscoli, Claudio ^g   Venditti, Mario ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF INSUBRIA   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g MONALDI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; C REACTIVE PROTEIN; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; STEROID; ECHINOCANDIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CANDIDA; CANDIDEMIA; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DEATH; DEVICE REMOVAL; ENDOCARDITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HUMAN; IMPLANTATION; MALE; MULTICENTER STUDY; NONHUMAN; OBSERVATIONAL STUDY; OPEN HEART SURGERY; PATHOPHYSIOLOGY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; RISK FACTOR; SEPSIS; STEROID THERAPY; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; ADOLESCENT; CANDIDIASIS; CHILD; CLASSIFICATION; CLINICAL TRIAL; INFECTION; ISOLATION AND PURIFICATION; ITALY; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; ECHINOCANDINS; ENDOCARDITIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; YOUNG ADULT;

EID: 66349121424     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181a693f8     Document Type: Article

References (39)

1. Bacak V, Biocina B, Starcevic B, Gertler S, Begovac J. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient-case report and review of literature. J Infect. 2006;53:e11-e14.
2. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, Lopez-Ribot JL. In vitro activity of caspofungin against Candida albicans biofilm. Antimicrob Agents Chemother. 2002; 46:3591-3596.
3. Baddley JW, Benjamin DK Jr, Patel M, Miro J, Athan E, Barsic B, Bouza E, Clara L, Elliott T, Kanafani Z, Klein J, Lerakis S, Levine D, Spelman D, Rubinstein E, Tornos P, Morris AJ, Pappas P, Fowler VG Jr, Chu VH, Cabell C. International Collaboration on Endocarditis-Prospective Cohort Study Group (ICE-PCS). Candida infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008;27:519-529.
4. Benjamin DK Jr, Miro JM, Hoen B, Steinbach WJ, Fowler VG Jr, Olaison L, Habib G, Abrutyn E, Perfect J, Zass A, Corey GR, Eykyn S, Thuny F, Jimenez-Exposito MJ, Cabell CH; ICE-MD Study Group. Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-MD). Scand J Infect Dis. 2004;36:453-455.
5. Bernhardt H, Zimmermann K, Knoke M. The continuous flow culture as an in vitro model in experimental mycology. Mycoses. 1999; 42(S2):29S-32S.
6. Challa S, Prayaga AK, Vemu L, Sadasivan J, Jagarlapudi MK, Digumarti R, Prabhala R. Fungal endocarditis: an autopsy study. Asian Cardiovasc Thorac Ann. 2004;12:95-98.
7. Daniel WG, Mugge A, Martin RP, Lindert O, Hausmann D, Nonnast-Daniel B, Laas J, Lichtlen PR. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324:795-800.
8. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200-209.
9. Ellis M. Fungal endocarditis. J Infect. 1997;35:99-103.
10. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62.
11. Fernandez-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A, Pahissa A. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis. 2008;47:1287-1297.
12. Gordon S, Keys T. Bloodstream infections in patients with prosthetic cardiac valves. Sem Thoracic Cardiovasc Surg. 1995;7:2-6.
13. Holzheimer RG. Antibiotic induced endotoxin release and clinical sepsis: a review. J Chemother. 2001;13:159-172.
14. Ivert T, Dismukes W, Cobb C, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation. 1984;69:223-232.
15. Jimenez-Exposito MJ, Torres G, Baraldes A, Jimenez-Exposito MJ, Torres G, Baraldes A, Benito N, Marco F, Pare JC, Moreno A, Claramonte X, Mestres CA, Almela M, Garcia de la Maria C, Perez N, Schell WA, Corey GR, Perfect J, Jimenez de Anta MT, Gatell JM, Miro JM. Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment. Clin Infect Dis. 2004;39:e70-e73.
16. Katragkou A, Chatzimoschou A, Simitsopoulou M, Dalakiouridou M, Diza-Mataftsi E, Tsantali C, Roilides E. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother. 2008;52:357-360.
17. Khan UM, Ali S, Baig MA, Rafig MA, Vasavada BC, Khan IA. Candida parapsilosis endocarditis 8 months after transient candidemia. Int J Cardiol. 2007;118:e58-e59.
18. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators. Results of a large prospective study. Circulation. 2007;116:1349-1355.
19. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 2002;46:1773-1780.
20. Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA; EPCAN Study Group. A bedside scoring system ("Candida Score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34:730-737.
21. Levy I, Shalit I, Birk E, Klinger G, Sirota L, Linder N. Candida endocarditis in neonates: report of five cases and review of the literature. Mycoses. 2006;49:43-48.
22. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638.
23. Lye DC, Hughes A, O'Brien D, Athan E. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis. 2005;24:753-755.
24. Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest. 2003;124:2244-2255.
25. Nandakumar R, Raju G. Isolated tricuspid valve endocarditis in nonaddicted patients: a diagnostic challenge. Am J Med Sci. 1997; 314:207-212.
26. Nasser RM, Melgar GR, Longworth GL, Gordon SM. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia. Am J Med. 1997;103:25-32.
27. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE; Infectious Diseases Society of America. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161-189.
28. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122:302-310.
29. Rajendram R, Alp NJ, Mitchell AR, Bowler ICJW, Forfar JC. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis. 2005;40:e72-e74.
30. Ramage G, Martinez JP, Lopez-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006;6:979-986.
31. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother. 2002;46:3634-3636.
32. Rubenstein E, Noriega ER, Simberkoff MS, Holzman R, Rahal JJ Jr. Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore). 1975;54:331-344.
33. Rubinstein E, Noriega ER, Simberkoff MS, Rahal JJ. Tissue penetration of amphotericin B in Candida endocarditis. Chest. 1974;66:376-377.
34. Ryan T, McCarthy JF, Rady MY, Serkey J, Gordon S, Starr NJ, Cosgrove DM. Early bloodstream infection after cardiopulmonary bypass: frequency rate, risk factors, and implications. Crit Care Med. 1997; 25:2009-2014.
35. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Lie JS, Zaasb AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230-247.
36. Talarmin JP, Boutoille D, Tattevin P, Abgueguen P, Ansart S, Roblot F, Raffi F. Candida endocarditis: role of new antifungal agents. Mycoses. 2009;52:60-66.
37. Tonomo K, Tsujino T, Fujioko Y. Candida parapsilosis endocarditis that emerged 2 years after abdominal surgery. Heart Vessels. 2004;19: 149-152.
38. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Pare C, Almirante B, Munoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabe J, Morris A, Corey GR, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354-1361.
39. Wilson WR, Jaumin PM, Danielson GK, Giuliani ER, Washington JA II, Geraci JE. Prosthetic valve endocarditis. Ann Intern Med. 1975; 82:751-756.